Escudo Universidad de Pamplona

Repositorio Institucional

Universidad de Pamplona

Preservamos, organizamos y difundimos la producción académica, científica, investigativa y cultural de la Universidad de Pamplona, garantizando el acceso abierto al conocimiento generado por nuestra comunidad universitaria.

Explorar colecciones

  1. Repositorio Institucional Universidad de Pamplona
  2. Trabajos de pregrado y especialización
  3. Facultad de Salud
  4. Medicina
Por favor, use este identificador para citar o enlazar este ítem: https://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/9170
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorCarvajal Caro, Lina María.-
dc.contributor.authorCastellanos Villamizar, Karla Geraldine.-
dc.date.accessioned2024-11-15T14:32:13Z-
dc.date.available2023-02-01-
dc.date.available2024-11-15T14:32:13Z-
dc.date.issued2023-
dc.identifier.citationCarvajal Caro, L. M.; Castellanos Villamizar, K. G. (2022). Manifestaciones cutáneas del SARS-COV-2: revisión de literatura [Trabajo de Grado Pregrado, Universidad de Pamplona]. Repositorio Hulago Universidad de Pamplona. http://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/9170es_CO
dc.identifier.urihttp://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/9170-
dc.descriptionLa enfermedad por coronavirus 19 (COVID-19) es una pandemia mundial en curso causada por el "coronavirus 2 síndrome respiratorio agudo severo" (SARS-CoV-2), que se aisló por primera vez en Wuhan (China) en diciembre de 2019. Común los síntomas incluyen fiebre, tos, fatiga, disnea e hipogeusia/hiposmia. Entre los signos extrapulmonares asociados a COVID-19, las manifestaciones dermatológicas se han reportado cada vez más en el contexto de la pandemia y en pacientes con antecedentes de infección por este nuevo patógeno. La naturaleza polimórfica de las manifestaciones cutáneas asociadas a COVID-19 ha llevado a múltiples clasificaciones en el ámbito académico, típicamente distingue seis patrones clínicos principales: (i) urticaria, (ii) erupción eritematosa / maculopapular / morbiliforme confluente, (iii) exantema pápulovesicular, (iv) patrón acral similares a perniosis, (v) patrón livedo reticularis / racemosa, (vi) patrón "vasculítico" purpúrico. Además de estas manifestaciones la pandemia también ha contribuido a un aumento importante de otras condiciones dermatológicas que deben de ser tenidas en cuenta por el personal de la salud.es_CO
dc.description.abstractCoronavirus 19 (COVID-19) disease is an ongoing global pandemic caused by "coronavirus 2 severe acute respiratory syndrome" (SARS-CoV-2), which was first isolated in Wuhan, China in December 2019. Common symptoms include fever, cough, fatigue, dyspnea, and hypogeusia / hyposmia. Among the extrapulmonary signs associated with COVID-19, dermatological manifestations have been increasingly reported in the context of the pandemic and in patients with a history of infection by this new pathogen. The polymorphic nature of the skin manifestations associated with COVID-19 has led to multiple classifications in the academic setting, typically distinguishing six main clinical patterns: (i) urticarial rash, (ii) confluent erythematous / maculopapular / morbilliform rash, (iii) papulovesicular rash, (iv) chilblain-like acral pattern, (v) livedo reticularis / racemosa pattern, (vi) purpuric "vasculitic" pattern. In addition to these manifestations, the pandemic has also contributed to a significant increase in other dermatological conditions that must be taken into account by health personnel.es_CO
dc.format.extent56es_CO
dc.format.mimetypeapplication/pdfes_CO
dc.language.isoeses_CO
dc.publisherUniversidad de Pamplona - Facultad de Salud.es_CO
dc.subjectCOVID-19.es_CO
dc.subjectCoronavirus.es_CO
dc.subjectManifestaciones cutáneas.es_CO
dc.subjectPiel.es_CO
dc.titleManifestaciones cutáneas del SARS-COV-2: revisión de literatura.es_CO
dc.typehttp://purl.org/coar/resource_type/c_7a1fes_CO
dc.date.accepted2022-11-01-
dc.relation.referencesLake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med Lond Eng. 2020; 20(2): p. 124-7.es_CO
dc.relation.referencesOtoya-Tono AM, García M, Jaramillo-Moncayo C, Willis C, Campos AM. COVID- 19: generalidades, comportamiento epidemiológico y medidas adoptadas en medio de la pandemia en Colombia. Acta de Otorrinolaringología& Cirugía de Cabeza y Cuello. 2020 Abril; E-Boletín: p. 4-13.es_CO
dc.relation.referencesRecalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020 May; 34(5): p. e212-e213.es_CO
dc.relation.referencesSánchez-Linares V, Nieda-Rosales L, Martínez-Cuervo JJ. Manifestaciones cutáneas de Covid-19. Gaceta Médica Espirituana. 2020; 22(3): p. 18-26.es_CO
dc.relation.referencesPeters AW, Chawla KS, Turnbull ZA. Transforming ORs into ICUs. N Engl J Med. 2020 May; 7(382): p. (19):e52.es_CO
dc.relation.referencesLoeb R, London MJ. Coronavirus disease 2019 (COVID-19): Intensive care ventilation with anesthesia machines. [Online].; 2020 [cited 2020 Octubre 10. Available from: https://www-uptodatecom.aure.unab.edu.co/contents/coronavirus-disease-2019-covid-19-intensive-careventilation-with-anesthesiamachines?search=Covid%20mechanical%20ventilation&source=search_result&sel ectedTitle=3~150&usage_type=default&display_rank=3.es_CO
dc.relation.referencesFullick J, Oliver M. “Water, water, everywhere”: a challenge to ventilators in the COVID-19 pandemic. Br J Anaesth. 2020 Jul; 125(1): p. e188–e190.es_CO
dc.relation.referencesMarzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol. 2020 Sep; 183(3): p. 431-442.es_CO
dc.relation.referencesMatar S, Oulès B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, Aractingi S. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature. J Eur Acad Dermatol Venereol. 2020 Nov; 34(11): p. e686-e689.es_CO
dc.relation.referencesGalván Casas C et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 Jun; 183(1): p. 71.es_CO
dc.relation.referencesde Masson, A, et al. Chilblains is a common cutaneous finding during the COVID- 19 pandemic: A retrospective nationwide study from France. J Am Acad Dermatol. 2020 Aug; 83(2): p. 667-670.es_CO
dc.relation.referencesFreeman, Esther E, et al. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020 Aug; 83(2): p. 486-492.es_CO
dc.relation.referencesDaneshgaran G, Dubin DP, Gould DJ. Cutaneous Manifestations of COVID-19: An Evidence-Based Review. Am J Clin Dermatol. 2020 Oct; 21(5): p. 627-639.es_CO
dc.relation.referencesWei-Jie, Guan et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr; 382(18): p. 1708-1720.es_CO
dc.relation.referencesMadigan LM, Micheletti RG, Shinkai K. How Dermatologists Can Learn and Contribute at the Leading Edge of the COVID-19 Global Pandemic. JAMA Dermatol. 2020 Jul; 156(7): p. 733-734.es_CO
dc.relation.referencesTürsen Ü, Türsen B, Lotti T. Cutaneous sıde-effects of the potential COVID-19 drugs. Dermatol Ther. 2020 Jul; 33(4): p. e13476.es_CO
dc.relation.referencesFreeman, Esther E, et al. The American Academy of Dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19. J Am Acad Dermatol. 2020 Aug; 83(2): p. 509-510.es_CO
dc.relation.referencesFreeman, Esther E, et al. The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020 Oct; 83(4): p. 1118-1129.es_CO
dc.relation.referencesDe Giorgi, Vincenzo, et al. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy. J Am Acad Dermatol. 2020 Aug; 83(2): p. 674-675.es_CO
dc.relation.referencesRivera-Oyola, Ryan et al. Dermatologic findings in 2 patients with COVID-19. JAAD Case Rep. 2020 Apr; 6(6): p. 537-539.es_CO
dc.relation.referencesJimenez-Cauhe J, Ortega-Quijano D, Prieto-Barrios M, Moreno-Arrones OM, Fernandez-Nieto D. Reply to "COVID-19 can present with a rash and be mistaken for dengue": Petechial rash in a patient with COVID-19 infection. J Am Acad Dermatol. 2020 Aug; 83(2): p. e141-e142.es_CO
dc.relation.referencesNajarian DJ. Morbilliform exanthem associated with COVID-19. JAAD Case Rep. 2020 Apr; 6(6): p. 493-494.es_CO
dc.relation.referencesCatalà, Alba et al. Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study. Dermatol Ther. 2020 Nov; 33(6): p. e14170.es_CO
dc.relation.referencesGenovese G, Moltrasio C, Berti E, Marzano AV. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology. 2021 Jan; 237(1): p. 1-12.es_CO
dc.relation.referencesSingh M, Pawar M, Bothra A, Choudhary N. Overzealous hand hygiene during the COVID 19 pandemic causing an increased incidence of hand eczema among general population. J Am Acad Dermatol. 2020 Jul; 83(1): p. e37-e41.es_CO
dc.relation.referencesGianotti R, Veraldi S, Recalcati S, Cusini M, Ghislanzoni M, Boggio F, Fox LP. Cutaneous Clinico-Pathological Findings in three COVID-19-Positive Patients Observed in the Metropolitan Area of Milan, Italy. Acta Derm Venereol. 2020 Apr; 100(8): p. adv00124.es_CO
dc.relation.referencesReymundo A, Fernáldez-Bernáldez A, Reolid A, Butrón B, Fernández-Rico P, Muñoz-Hernández P, De Argila D, Wiesner T, Llamas-Velasco M. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients. J Eur Acad Dermatol Venereol. 2020 Dec; 34(12): p. e755-e757.es_CO
dc.relation.referencesHerrero-Moyano M, Capusan TM, Andreu-Barasoain M, Alcántara-González J, Ruano-Del Salado M, Sánchez-Largo Uceda ME, Calzado-Villarreal L, PérezGonzález Y. A clinicopathological study of eight patients with COVID-19 pneumonia and a late-onset exanthema. J Eur Acad Dermatol Venereol. 2020 Sep; 34(9): p. e460-e464.es_CO
dc.relation.referencesMazzotta F, Troccoli T. Acute acro-ischemia in the child at the time of COVID-19. Eur J Pediatr Dermatol. 2020; 30(2): p. 71–4.es_CO
dc.relation.referencesColonna C, Genovese G, Monzani NA, Picca M, Boggio F, Gianotti R, et al. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic. J Am Acad Dermatol. 2020 Sep; 83(3): p. 965-9.es_CO
dc.relation.referencesAlramthan A, Aldaraji W. Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East. Clin Exp Dermatol. 2020 Aug; 45(6): p. 746-8.es_CO
dc.relation.referencesFernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D, Arana-Raja A, et al. Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak. J Am Acad Dermatol. 2020 Jul; 83(1): p. e61–3.es_CO
dc.relation.referencesBouaziz JD, Duong TA, Jachiet M, Velter C, Lestang P, Cassius C, et al. Vascular skin symptoms in COVID-19: a French observational study. J Eur Acad Dermatol Venereol. 2020 Apr; 34(9): p. https://doi.org/10.1111/jdv.16544.es_CO
dc.relation.referencesCordoro KM, Reynolds SD, Wattier R, McCalmont TH. Clustered cases of acral perniosis: clinical features, histopathology, and relationship to COVID-19. Pediatr Dermatol. 2020 May; 37(3): p. 419–23.es_CO
dc.relation.referencesDeutsch A, Blasiak R, Keyes A, Wu J, Marmon S, Asrani F, et al. Covid toes: phenomenon or epiphenomenon? J Am Acad Dermatol. 2020; 83(5): p. e347–e348.es_CO
dc.relation.referencesZhou Z, Ren L, Zhang L, Zhong J, Xiao Y, Jia Z, et al. Overly exuberant innate immune response to SARS-CoV-2 infection. SSRN Electronic J. 2020;: p. 10.2139/ssrn.3551623.es_CO
dc.relation.referencesKaya G, Kaya A, Saurat JH. Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: review of the Literature. Dermatopathology (Basel). 2020 Jun; 7(1): p. 3–16.es_CO
dc.relation.referencesPiccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G, Battarra VC, et al. Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients. J Eur Acad Dermatol Venereol. 2020 Jul; 34(7): p. e291–3.es_CO
dc.relation.referencesProietti I, Tolino E, Bernardini N, Mambrin A, Balduzzi V, Marchesiello A, et al. Auricle perniosis as a manifestation of Covid-19 infection. Dermatol Ther (Heidelb). 2020 Jul;: p. e14089.es_CO
dc.relation.referencesNavarro L, Andina D, Noguera-Morel L, Hernández-Martín A, Colmenero I, Torrelo A. Dermoscopy features of COVID-19-related chilblains in children and adolescents. J Eur Acad Dermatol Venereol. 2020 Jul;: p. jdv.16800.es_CO
dc.relation.referencesLocatelli AG, Robustelli Test E, Vezzoli P, Carugno A, Moggio E, Consonni L, et al. Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient. J Eur Acad Dermatol Venereol. 2020 Aug; 34(8): p. e365–8.es_CO
dc.relation.referencesHubiche, Thomas, et al. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic. JAMA Dermatol. 2021 Feb; 157(2): p. 202-206.es_CO
dc.relation.referencesFeldman SR, Freeman EE. UpToDate - COVID-19: Cutaneous manifestations and issues related to dermatologic care. [Online].; 2021 [cited 2021 05 19. Available from: https://www.uptodate.com/contents/covid-19-cutaneous-manifestationsand-issues-related-to-dermatologic-care#H1181096409.es_CO
dc.relation.referencesGuarneri, C, et al. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19. J Eur Acad Dermatol Venereol. 2020 Sep; 34(9): p. e449- e450.es_CO
dc.relation.referencesImbalzano E, Casciaro M, Quartuccio S, Minciullo PL, Cascio A, Calapai G, et al. Association between urticaria and virus infections: A systematic review. Allergy Asthma Proc. 2016 Jan-Feb; 37(1): p. 18-22.es_CO
dc.relation.referencesYong SB, Yeh WC, Wu HJ, Chen HH, Huang JY, Chang TM, et al. Impact of mycoplasma pneumonia infection on urticaria: A nationwide, population-based retrospective cohort study in Taiwan. PLoS One. 2019; 14(12): p. e0226759.es_CO
dc.relation.referencesYoung S, Fernandez AP. Skin manifestations of COVID-19. Cleveland Clinic Journal of Medicine. 2020 May;: p. https://doi.org/10.3949/ccjm.87a.ccc031.es_CO
dc.relation.referencesvan Damme C, Berlingin E, Saussez S, Accaputo O. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection. J Eur Acad Dermatol Venereol. 2020 Jul; 34(7): p. e300–1.es_CO
dc.relation.referencesQuintana-Castanedo L, Feito-Rodríguez M, Valero-López I, Chiloeches-Fernández C, Sendagorta-Cudós E, Herranz-Pinto P. Urticarial exanthem as early diagnostic clue for COVID-19 infection. JAAD Case Rep. 2020 Apr; 6(6): p. 498–9.es_CO
dc.relation.referencesHassan K. Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection. BMJ Case Rep. 2020 Jul; 13(7): p. e236981.es_CO
dc.relation.referencesCepeda-Valdes R, Carrion-Alvarez D, Trejo-Castro A, Hernandez-Torre M, SalasAlanis J. Cutaneous manifestations in COVID-19: familial cluster of urticarial rash. Clin Exp Dermatol. 2020 May; 45(7): p. 895–6.es_CO
dc.relation.referencesde Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, Selda-Enriquez G, Carretero I, Moreno C, et al. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? J Eur Acad Dermatol Venereol. 2020 Oct; 34(10): p. e566–8.es_CO
dc.relation.referencesRodríguez-Jiménez P, Chicharro P, De Argila D, Muñoz-Hernández P, LlamasVelasco M. Urticaria-like lesions in COVID-19 patients are not really urticaria - a case with clinicopathological correlation. J Eur Acad Dermatol Venereol. 2020 May; 34(9): p. https://doi.org/10.1111/jdv.16618.es_CO
dc.relation.referencesAmatore F, Macagno N, Mailhe M, Demarez B, Gaudy-Marqueste C, Grob JJ, et al. SARS-CoV-2 infection presenting as a febrile rash. J Eur Acad Dermatol Venereol. 2020 Jul; 34(7): p. e304–6.es_CO
dc.relation.referencesShanshal M. Low-dose systemic steroids, an emerging therapeutic option for COVID-19-related urticaria. J Dermatolog Treat. 2020 Jul; 16(1-2): p. 10.1080/09546634.2020.1795062.es_CO
dc.relation.referencesMarzano AV, Genovese G, Fabbrocini G, Pigatto P, Monfrecola G, Piraccini BM, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020 Jul; 83(1): p. 280– 5.es_CO
dc.relation.referencesAskin O, Altunkalem RN, Altinisik DD, Uzuncakmak TK, Tursen U, Kutlubay Z. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19. Dermatol Ther (Heidelb). 2020 Jun; 24: p. e13896.es_CO
dc.relation.referencesGenovese G, Colonna C, Marzano AV. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue? Pediatr Dermatol. 2020 May; 37(3): p. 435–6.es_CO
dc.relation.referencesFernandez-Nieto D, Ortega-Quijano D, Jimenez-Cauhe J, Burgos-Blasco P, de Perosanz-Lobo D, Suarez-Valle A, et al. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol. 2020 May; 45(7): p. 872–5.es_CO
dc.relation.referencesMahé A, Birckel E, Merklen C, Lefèbvre P, Hannedouche C, Jost M, et al. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not ‘varicella-like’. J Eur Acad Dermatol Venereol. 2020 Oct; 34(10): p. e559–61.es_CO
dc.relation.referencesTrellu LT, Kaya G, Alberto C, Calame A, McKee T, Calmy A. Clinicopathologic Aspects of a Papulovesicular Eruption in a Patient With COVID-19. JAMA Dermatol. 2020 Aug; 156(8): p. 922–4.es_CO
dc.relation.referencesTammaro A, Adebanjo GA, Parisella FR, Pezzuto A, Rello J. Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome. J Eur Acad Dermatol Venereol. 2020 Jul; 34(7): p. e306–7.es_CO
dc.relation.referencesElsaie ML, Nada HA. Herpes zoster (shingles) complicating the course of COVID- 19 infection. J Dermatolog Treat. 2020 Oct;: p. DOI: 10.1080/09546634.2020.1782823.es_CO
dc.relation.referencesLim SY, Tey HL. Response to ‘Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases’: vesicular eruption in COVID-19 - to exclude varicella. Br J Dermatol. 2020 Oct; 183(4): p. 790–1.es_CO
dc.relation.referencesLlamas-Velasco M, Rodríguez-Jiménez P, Chicharro P, De Argila D, MuñozHernández P, Daudén E. Reply to “Varicella-like exanthem as a specific COVID- 19-associated skin manifestation: Multicenter case series of 22 patients”: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled ou. J Am Acad Dermatol. 2020 Sep; 83(3): p. e253–4.es_CO
dc.relation.referencesMarzano AV, Genovese G. Response to: "Reply to 'Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients': To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex mu. J Am Acad Dermatol. 2020 Sep; 83(3): p. e255–e256.es_CO
dc.relation.referencesGriffiths C, Barker J, Bleiker T, Chalmers R, Creamer D. Rook’s textbook of dermatology. 9th ed. 9th ed. Hoboken: Wiley‐Blackwell; 2016.es_CO
dc.relation.referencesKhalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R. Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection. JAAD Case Rep. 2020 Sep; 6(9): p. 871–4.es_CO
dc.relation.referencesManalo IF, Smith MK, Cheeley J, Jacobs R. A dermatologic manifestation of COVID-19: transient livedo reticularis. J Am Acad Dermatol. 2020 Aug; 83(2): p. 700.es_CO
dc.relation.referencesKo CJ, Harigopal M, Damsky W, Gehlhausen JR, Bosenberg M, Patrignelli R, et al. Perniosis during the COVID-19 pandemic: negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2. Cutan Pathol. 2020 Aug; 47(11): p. 997–1002.es_CO
dc.relation.referencesBosch-Amate X, Giavedoni P, Podlipnik S, Andreu-Febrer C, Sanz-Beltran J, Garcia-Herrera A, et al. Retiform purpura as a dermatological sign of coronavirus disease 2019 (COVID-19) coagulopathy. J Eur Acad Dermatol Venereol. 2020 Oct; 34(10): p. e548–9.es_CO
dc.relation.referencesNegrini S, Guadagno A, Greco M, Parodi A, Burlando M. An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient. J Eur Acad Dermatol Venereol. 2020 Jun;: p. jdv.16760.es_CO
dc.relation.referencesGarcía-Gil MF, Monte Serrano JGarcía García M, Barra Borao V, Matovelle Ochoa C, Ramirez-Lluch M, et al. Acral purpuric lesions associated with coagulation disorders during the COVID-19 pandemic. Int J Dermatol. 2020 Sep; 59(9): p. 1151– 2.es_CO
dc.relation.referencesCaputo V, Schroeder J, Rongioletti F. A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19. J Eur Acad Dermatol Venereol. 2020 Oct; 34(10): p. e579–81.es_CO
dc.relation.referencesLarrondo J, Cabrera R, Gosch M, Larrondo F, Aylwin M, Castro A. Papularpurpuric exanthem in a COVID-19 patient: clinical and dermoscopic description. J Eur Acad Dermatol Venereol. 2020 Oct; 34(10): p. e570–2.es_CO
dc.relation.referencesKaraca Z, Yayli S, Çalışkan O. A unilateral purpuric rash in a patient with COVID- 19 infection. Dermatol Ther (Heidelb). 2020 Jul; 33(4): p. e13798.es_CO
dc.relation.referencesJoob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020 May; 82(2): p. e177.es_CO
dc.relation.referencesDel Giudice P, Boudoumi D, Le Guen B, Reverte M, Gutnecht J, Lacour JP, et al. Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy. J Eur Acad Dermatol Venereol. 2020 Jun;: p. jdv.16763.es_CO
dc.relation.referencesJimenez-Cauhe J, Ortega-Quijano D, Carretero-Barrio I, Suarez-Valle A, SacedaCorralo D, Moreno-Garcia Del Real C, et al. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Clin Exp Dermatol. 2020 May; 45(7): p. 892–5.es_CO
dc.relation.referencesEhsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.. J Eur Acad Dermatol Venereol. 2020 May; 34(9): p. https://doi.org/10.1111/jdv.16579.es_CO
dc.relation.referencesGupta A, Gill A, Sharma M, Garg M. Multi-System Inflammatory Syndrome in a Child Mimicking Kawasaki Disease. J Trop Pediatr. 2020 Aug;: p. fmaa060.es_CO
dc.relation.referencesShanshal M. COVID-19 related anagen effluvium. J Dermatolog Treat. 2020 Jul; 16(1-2): p. DOI: 10.1080/09546634.2020.1792400.es_CO
dc.relation.referencesLlamas-Velasco M, Chicharro P, Rodríguez-Jiménez P, Martos-Cabrera L, De Argila D, Fernández-Figueras M, et al. Comment on ‘Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital’. Pseudoherpetic Grover disease seems to occur in patients with COVID-19 infection. Clin Exp Dermatol. 2020 May; 45(7): p. 896–8.es_CO
dc.relation.referencesLin, P, et al. Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regions. Br J Dermatol. 2020 Jul; 183(1): p. 190-192.es_CO
dc.relation.referencesLan, Jiajia et al. Skin damage among health care workers managing coronavirus disease-2019. J Am Acad Dermatol. 2020 May; 82(5): p. 1215-1216.es_CO
dc.relation.referencesJiang, Qixia, et al. The Prevalence, Characteristics, and Prevention Status of Skin Injury Caused by Personal Protective Equipment Among Medical Staff in Fighting COVID-19: A Multicenter, Cross-Sectional Study. Adv Wound Care (New Rochelle). 2020 Jul; 9(7): p. 357-364.es_CO
dc.relation.referencesDaye M, Gökşin Cihan F, Durduran Y. Evaluation of skin problems and dermatology life quality index in health care workers who use personal protection measures during COVID-19 pandemic. Dermatol Ther. 2020 Nov; 33(6): p. e14346.es_CO
dc.relation.referencesBattista RA, Ferraro M, Piccioni LO, Malzanni GE, Bussi M. Personal Protective Equipment (PPE) in COVID 19 Pandemic: Related Symptoms and Adverse Reactions in Healthcare Workers and General Population. J Occup Environ Med. 2021 Feb; 63(2): p. e80-e85.es_CO
dc.relation.referencesYu J, Chen JK, Mowad CM, Reeder M, Hylwa S, Chisolm S, Dunnick CA, Goldminz AM, Jacob SE, Wu PA, Zippin J, Atwater AR. Occupational dermatitis to facial personal protective equipment in health care workers: A systematic review. J Am Acad Dermatol. 2021 Feb; 84(2): p. 486-494.es_CO
dc.relation.referencesTechasatian L, Lebsing S, Uppala R, Thaowandee W, Chaiyarit J, Supakunpinyo C, Panombualert S, Mairiang D, Saengnipanthkul S, Wichajarn K, Kiatchoosakun P, Kosalaraksa P. The Effects of the Face Mask on the Skin Underneath: A Prospective Survey During the COVID-19 Pandemic. J Prim Care Community Health. 2020 JanDec;: p. doi: 10.1177/2150132720966167.es_CO
dc.relation.referencesDamiani G, Gironi LC, Grada A, Kridin K, Finelli R, Buja A, Bragazzi NL, Pigatto PDM, Savoia P. COVID-19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): Multi-center, real-life, telemedical, and observational prospective study. Dermatol Ther. 2021 Mar; 34(2): p. e14848.es_CO
dc.relation.referencesDamiani G, Gironi LC, Kridin K, Pacifico A, Buja A, Bragazzi NL, Spalkowska M, Pigatto PDM, Santus P, Young Dermatologists Italian Network, Savoia P. Maskinduced Koebner phenomenon and its clinical phenotypes: A multicenter, real-life study focusing on 873 dermatological consultations during COVID-19 pandemics. Dermatol Ther. 2021 Mar; 34(2): p. e14823.es_CO
dc.relation.referencesKantor J. Behavioral considerations and impact on personal protective equipment use: Early lessons from the coronavirus (COVID-19) pandemic. J Am Acad Dermatol. 2020 May; 82(5): p. 1087-1088.es_CO
dc.relation.referencesPatruno C, Fabbrocini G, Stingeni L, Napolitano M. The role of occupational dermatology in the COVID-19 outbreak. Contact Dermatitis. 2020 Aug; 83(2): p. 174-175.es_CO
dc.relation.referencesSingh H, Kaur H, Singh K, Sen CK. Cutaneous Manifestations of COVID-19: A Systematic Review. Advances in Wound Care. 2020 Dec; 10(2): p. https://doi.org/10.1089/wound.2020.1309.es_CO
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2es_CO
dc.type.coarversionhttp://purl.org/coar/resource_type/c_2df8fbb1es_CO
Aparece en las colecciones: Medicina

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Carvajal_Castellanos_2022_TG.pdfCarvajal_Castellanos_2022_TG1,5 MBAdobe PDFVisualizar/Abrir
Mostrar el registro sencillo del ítem


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.